| Code | Description | Claims | Beneficiaries | Total Paid |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,696 |
2,255 |
$41K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
757 |
668 |
$38K |
| 80061 |
Lipid panel |
2,704 |
2,205 |
$33K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,518 |
3,666 |
$30K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
641 |
564 |
$14K |
| 80053 |
Comprehensive metabolic panel |
1,346 |
1,034 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,647 |
1,447 |
$12K |
| 81000 |
|
3,645 |
2,914 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,103 |
861 |
$10K |
| 82274 |
|
673 |
543 |
$9K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
297 |
192 |
$8K |
| 80076 |
|
736 |
616 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
118 |
74 |
$4K |
| 86328 |
|
184 |
184 |
$3K |
| 87276 |
|
253 |
194 |
$3K |
| 82043 |
|
645 |
474 |
$3K |
| 87275 |
|
253 |
194 |
$3K |
| 86738 |
|
233 |
174 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
187 |
187 |
$2K |
| 86701 |
|
188 |
153 |
$2K |
| 84153 |
|
82 |
73 |
$1K |
| 82570 |
|
214 |
138 |
$1K |
| 86301 |
|
44 |
42 |
$795.96 |
| 87088 |
|
103 |
80 |
$776.67 |
| 82378 |
|
45 |
43 |
$718.25 |
| 87186 |
|
93 |
82 |
$717.41 |
| 82105 |
|
49 |
45 |
$704.50 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
19 |
14 |
$606.49 |
| 86592 |
|
156 |
122 |
$592.12 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
78 |
68 |
$549.83 |
| 85730 |
|
55 |
28 |
$330.79 |
| 84439 |
|
38 |
24 |
$314.01 |
| 85610 |
|
55 |
28 |
$235.06 |
| 86803 |
|
18 |
12 |
$223.22 |
| 87590 |
|
19 |
14 |
$212.36 |
| 86800 |
|
13 |
13 |
$166.42 |
| 86376 |
|
12 |
12 |
$139.57 |
| 87070 |
|
14 |
13 |
$103.30 |
| 87077 |
|
14 |
13 |
$96.72 |